Stevanato Group S.p.A. (NYSE:STVN) Given Consensus Rating of “Hold” by Brokerages

Shares of Stevanato Group S.p.A. (NYSE:STVN) have earned an average rating of “Hold” from the five analysts that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and three have given a buy recommendation to the company.

STVN has been the topic of a number of recent research reports. Wall Street Zen lowered shares of Stevanato Group from a “buy” rating to a “hold” rating in a research note on Saturday, February 14th. KeyCorp dropped their price objective on shares of Stevanato Group from $37.00 to $32.00 and set an “overweight” rating on the stock in a research note on Thursday, March 5th. Jefferies Financial Group set a $17.50 price objective on shares of Stevanato Group in a research note on Tuesday, February 10th. Morgan Stanley dropped their price target on shares of Stevanato Group from $24.00 to $19.00 and set an “equal weight” rating on the stock in a research note on Friday, March 6th. Finally, Weiss Ratings lowered shares of Stevanato Group from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, March 11th.

Key Headlines Impacting Stevanato Group

Here are the key news stories impacting Stevanato Group this week:

• Positive Sentiment: Stevanato posted first-quarter 2026 revenue of €273.6 million, up 7% year over year and 10% at constant currency, driven by high-value solutions growth. Article Title
• Positive Sentiment: The company’s Q1 earnings came in at about €0.11–€0.13 per share, with one report noting a beat versus the €0.12 consensus, helping support the stock’s rebound. Article Title
• Positive Sentiment: Stevanato maintained its 2026 revenue guidance of €1.260 billion to €1.290 billion, signaling confidence in demand and execution despite macro uncertainty. Article Title
• Positive Sentiment: Management highlighted progress toward RTU cartridge production beginning in early 2027, which could expand the company’s addressable market and support longer-term growth. Article Title
• Neutral Sentiment: The company also filed a Form 6-K and held its Q1 earnings call, which mainly provided additional detail on the quarterly update rather than new material surprises. Article Title
• Neutral Sentiment: Coverage on valuation after the recent share-price rebound suggests investors are now weighing whether the stock’s recovery has already priced in some of the near-term earnings improvement. Article Title

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. ArrowMark Colorado Holdings LLC increased its stake in shares of Stevanato Group by 6.7% during the third quarter. ArrowMark Colorado Holdings LLC now owns 1,392,581 shares of the company’s stock worth $35,859,000 after acquiring an additional 86,971 shares during the period. Pembroke Management LTD grew its position in Stevanato Group by 11.9% during the third quarter. Pembroke Management LTD now owns 1,283,216 shares of the company’s stock worth $33,043,000 after buying an additional 136,710 shares during the period. Thrivent Financial for Lutherans grew its position in Stevanato Group by 7.1% during the third quarter. Thrivent Financial for Lutherans now owns 2,372,390 shares of the company’s stock worth $61,089,000 after buying an additional 156,733 shares during the period. Cooper Investors PTY Ltd. grew its position in Stevanato Group by 17.8% during the fourth quarter. Cooper Investors PTY Ltd. now owns 695,245 shares of the company’s stock worth $13,988,000 after buying an additional 104,937 shares during the period. Finally, Bamco Inc. NY grew its position in Stevanato Group by 4.5% during the third quarter. Bamco Inc. NY now owns 1,973,759 shares of the company’s stock worth $50,824,000 after buying an additional 85,709 shares during the period.

Stevanato Group Price Performance

Stevanato Group stock opened at €18.23 on Monday. The stock has a market cap of $5.52 billion, a P/E ratio of 30.90, a price-to-earnings-growth ratio of 1.61 and a beta of 0.75. The company has a fifty day simple moving average of €15.16 and a 200-day simple moving average of €18.75. Stevanato Group has a 12-month low of €12.89 and a 12-month high of €28.00. The company has a current ratio of 1.76, a quick ratio of 1.26 and a debt-to-equity ratio of 0.23.

Stevanato Group (NYSE:STVN) last posted its quarterly earnings data on Friday, May 8th. The company reported €0.11 EPS for the quarter, missing analysts’ consensus estimates of €0.12 by (€0.01). The business had revenue of €273.57 million during the quarter. Stevanato Group had a net margin of 11.76% and a return on equity of 10.49%. The business’s revenue for the quarter was up 6.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.10 EPS. Equities analysts expect that Stevanato Group will post 0.7 EPS for the current fiscal year.

About Stevanato Group

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.